News
MAPS
1.240
-2.36%
-0.030
Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling
US Drug Enforcement Administration will reschedule cannabis from a Schedule 1 drug to a Schedule 3. The proposed rescheduling of cannabis is the biggest step forward for the cannabis industry in decades. Most cannabis companies will see immediate financial and operational benefits from the move. Cannabis has been in a bull market since last August.
Seeking Alpha · 1d ago
Cannabis Stocks React To DEA Rescheduling: Canopy & Aurora Surge, Tilray, WM Tech Hold Steady
The DEA's decision to reclassify marijuana from Schedule I to Schedule III sparked gains in major cannabis stocks on the NASDAQ. Canopy Growth Corporation, Aurora Cannabis and Tilray Brands led the gains on Tuesday. However, these stocks have shown high volatility throughout the year. The DEA's move could change the landscape of the cannabis industry.
Benzinga · 4d ago
"Schumer Says DEA Marijuana Rescheduling Decision Is 'Historic,' But He Remains 'Strongly Committed' To Passing Banking And Legalization Bills" - Marijuana Moment
Senate Majority Leader Chuck Schumer says he's committed to advancing cannabis banking and legalization legislation this session. The DEA has proposed rescheduling cannabis from Schedule I to Schedule III of the Controlled Substances Act. Schumer says the decision is a "historic step forward" but he remains committed to the legislation.
Benzinga · 4d ago
Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana
The DEA moved marijuana from Schedule I to Schedule III under the Controlled Substances Act. The DEA's decision aligns with a recommendation from the Department of Health and Human Services to reschedule cannabis. The cannabis sector saw a notable upswing on Tuesday after the announcement.
Benzinga · 4d ago
Pot stocks surge on news of cannabis rescheduling
Pot stocks surge on news of cannabis rescheduling. The DEA is set to reclassify marijuana as a less dangerous drug. U.S. Multi-state operators have recorded double-digit percentage gains. Cannabis-related stocks rose sharply higher in afternoon trading Tuesday.
Seeking Alpha · 4d ago
DEA Moving To Reclassify Marijuana As Less Dangerous Drug
Benzinga · 4d ago
2024 Winners Unveiled for “Best of Weedmaps” Program
Weedmaps named the 2024 winners of the “Best of Weedmaps: The People’s Choice” awards. The 2024 program aims to celebrate the businesses, delivery operators and brands who are working to elevate the cannabis shopping experience on the Weedmaps platform. Winners in the dispensary category had 6x more orders than semifinalists.
Barchart · 5d ago
Weekly Report: what happened at MAPS last week (0422-0426)?
Weekly Report · 6d ago
After The 4/20 Smoke Clears: What Do The Billions Spent On Cannabis Say About Sales In Key States?
The overall week of 4/20 saw 3x the sales and units sold compared to any typical week. Over half a million transactions were handled on the same day. Illinois and Colorado led the way in sales for the week. The top-selling product categories were flowers and pre-rolls. Data-driven platforms played a key role in driving sales.
Benzinga · 04/23 21:31
Weekly Report: what happened at MAPS last week (0415-0419)?
Weekly Report · 04/22 09:13
Unparalleled 4/20: Weedmaps Unveils Consumer Trends Ahead Of Cannabis Industry's Biggest Holiday
Weedmaps has forecast a significant sales boost for the industry on 4/20. The platform registered a 200% surge in orders that redeem deals through the platform. The average order value surged to $96.22 in 2023 compared to the previous year. Big data analysis of user activities on the platform shows consumers are prioritizing value.
Benzinga · 04/19 22:44
'Cannabis Seizures At Checkpoints By U.S.-Mexico Border Frustrates State-Authorized Pot Industry' - Audacy Citing AP
U.S. Border Patrol says it has the right to seize cannabis shipments at checkpoints in southern New Mexico. More than $300,000 worth of marijuana has been seized in recent months at checkpoints. New Mexico's governor says she's working to protect the state's legalized cannabis industry. Cannabis is still a "Schedule 1" drug.
Benzinga · 04/19 19:37
'Senator Presses Attorney General Garland On Marijuana Banking Bill's Impact On Criminal Investigations' - Marijuana Moment
Democratic senator presses attorney general about a bipartisan marijuana banking bill. Sen. Jack Reed asked Merrick Garland for his opinion on a controversial section of the bill. Section 10 of the original bill would have required banks to notify criminals when their accounts are terminated. Garland says he can't comment on the specific provisions of the legislation.
Benzinga · 04/17 17:12
12 Information Technology Stocks Moving In Monday's After-Market Session
Gainers My Size (NASDAQ:MYSZ) stock increased by 12.6% to $0.5 during Monday's after-market session. Abits Group and Red Cat Hldgs also saw their shares move upwards. Losers Mobix Labs and Mitek Systems reported their Q1 earnings report today.
Benzinga · 04/15 20:31
'Marijuana Companies Ask Federal Court To Set Oral Arguments On DOJ Claim That Cannabis 'Tourism' Justifies Prohibition Enforcement' - Marijuana Moment
Marijuana companies are asking a federal court to schedule oral arguments in a case against the federal government. The Justice Department says cannabis legalization attracts out-of-state tourism and justifies prohibition. The companies are seeking to shield their in-state activities from federal enforcement. DOJ has filed a motion to dismiss the suit.
Benzinga · 04/15 19:26
Weekly Report: what happened at MAPS last week (0408-0412)?
Weekly Report · 04/15 09:13
Brent crude tops $90 on Mideast fears, but IEA sees slower global oil demand growth
Crude oil futures settle higher Friday after touching their highest intraday levels in six months. The IEA sees slower global oil demand growth for 2024. The energy sector ended the week with losses for the full week. U.S. Crude stocks rose sharply and inflation came in hotter than expected.
Seeking Alpha · 04/12 23:35
WM Technology announces receipt of Nasdaq notification of delinquency
WM Technology announces receipt of Nasdaq notification of delinquency. Shares of MAPS fell 3.1% in extended trading. Nasdaq says MAPS has failed to timely file its Annual Report on Form 10-K for the year ended December 31, 2023. This notification has no immediate effect on the listing of the company's securities on Nasdaq.
Seeking Alpha · 04/09 20:58
WM Technology Receives Delinquency Notification Letter From Nasdaq's Listing Qualifications Department On April 2, 2024
Company must submit a plan to regain compliance with the Nasdaq listing rules within 60 calendar days. Nasdaq says the Company must submit the plan by June 3, 2024. This notification has no immediate effect on the listing of the Company's securities on Nasdaq.
Benzinga · 04/09 20:25
WM TECHNOLOGY, INC. ANNOUNCES NOTIFICATION OF DELINQUENCY WITH NASDAQ
Reuters · 04/09 20:17
More
Webull provides a variety of real-time MAPS stock news. You can receive the latest news about Wm Technology Inc through multiple platforms. This information may help you make smarter investment decisions.
About MAPS
WM Technology, Inc. operates the online cannabis marketplace for consumers together with a set of eCommerce and compliance software solutions for cannabis businesses, which are sold to retailers and brands in the United States and Canadian cannabis markets. The Company’s business primarily consists of its commerce-driven marketplace (Weedmaps), and its fully integrated suite of end-to-end software-as-a-service (SaaS) solutions software offering (Weedmaps for Business). The Weedmaps marketplace provides cannabis consumers with information regarding cannabis retailers and brands. In addition, the Weedmaps marketplace aggregates data from a variety of sources, including retailer point-of-sale solutions to provide consumers to browse by strain, price, cannabinoids and other information regarding locally available cannabis products, through the Company’s website and mobile apps. Its subscription package includes WM Listings, WM Listings, WM Listings, WM Connectors and WM Insights.